Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanomik Biyoteknoloji Anonim Sirketi has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, ROSSI, JULIA ANNE LORRAIN, who is the busiest examiner for the company. The prosecution is limited to 1 distinct art unit.
ROSSI, JULIA ANNE LORRAIN is responsible for 1 busiest examiner pending office action, which is the 1 total pending office action for the portfolio. The alignment of 1 pending office action with 1 distinct examiner and 1 distinct art unit indicates a focused examination for the Biotechnology & Pharmaceuticals filing. This structure ensures that the company's current prosecution effort is concentrated on the review of 1 distinct examiner within a single technical unit. Practitioners can tailor their strategy to the specific requirements of this 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSSI, JULIA ANNE LORRAIN | 1 | 45.7% | +61.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726901 | MICROENCAPSULATED ESSENTIAL OILS | ROSSI, JULIA ANNE LORRAIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726901 | MICROENCAPSULATED ESSENTIAL OILS | ROSSI, JULIA ANNE LORRAIN | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18726901 | MICROENCAPSULATED ESSENTIAL OILS | ROSSI, JULIA ANNE LORRAIN | 1615 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanomik Biyoteknoloji Anonim Sirketi has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Julia Anne Lorrain Rossi has the most, with 1 of Nanomik Biyoteknoloji Anonim Sirketi's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
